https://www.selleckchem.com/pr....oducts/hpk1-in-2.htm
It is approved by the Clinical Research Society of our hospital. According to the 11 ratio, the patients will be randomly divided into Tanreqing injection combined with azithromycin group (observation group) and azithromycin group (control group). Duration of hospitalization, clinical improvement 7 days after admission, changing laboratory tests, pulmonary function, immunoglobulin level, and adverse reactions will be compared between the 2 groups. The data will be analyzed by SPSS 16.0 software. This study will evaluate the efficacy a
Like
Comment
Share
